Zydus Worldwide DMCC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea (NCT04106726) | Zydus Worldwide DMCC | 2019-10-17 |
Track Zydus Worldwide DMCC automatically
Every clearance here is in the API, with alerts when new ones post.